GlassScriptPhysician profile
Karli Qualls
NPI 1679904494
$25,301.27
in general payments reported to CMS, 2019-2025
18 companies · $10K in 2025
The $10K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,187 · 2022: $2,790 · 2023: $5,665 · 2024: $5,351 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $5,300 · Food and Beverage: $2,934 · Education: $91.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Travel and Lodging | $5,299.62 |
| Food and Beverage | $2,933.52 |
| Education | $91.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,186.15 | 2021-2025 | Watchman Access System, Watchman, Watchman Flx |
| Edwards Lifesciences Corporation | $4,530.83 | 2021-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,080.87 | 2021-2025 | Mitraclip, Navitor |
| Medtronic, INC. | $1,618.58 | 2023 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $382.10 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $98.34 | 2021-2024 | Xarelto |
| Amgen INC. | $83.79 | 2023-2025 | Repatha, Repatha |
| Heartflow, INC. | $75.53 | 2022-2025 | |
| Pfizer INC. | $55.63 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.63 | 2022-2023 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $26.91 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.24 | 2023 | Jardiance |
| Baxter Healthcare | $20.23 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Esperion Therapeutics, INC. | $19.61 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.12 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $17.07 | 2024 | Impella |
| Chiesi USA, INC. | $16.20 | 2024 | Cleviprex, Kengreal |
| Astrazeneca Pharmaceuticals LP | $14.44 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karli Qualls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.